









Markets
/
Stocks
/
nasdaq-bcli
/

Brainstorm Cell Therapeutics Inc

BCLI

View Detailed Chart

1.170USD

-0.030-2.50%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

9.26MMarket Cap

LossP/E TTM



Brainstorm Cell Therapeutics Inc

1.170

-0.030-2.50%

Overview Company Financials

Financials

Intraday

30m

Today

-2.50%

5 Days

0.00%

1 Month

+0.86%

6 Months

-36.24%

Year to Date

-48.46%

1 Year

-75.81%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

HOLD

Current Rating

19.755

Target Price

1588.46%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Brainstorm Cell Therapeutics Inc

BCLI

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(4)

Buy(1)

Indicators

Sell(1)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.001

Buy

RSI(14)

48.724

Neutral

STOCH(KDJ)(9,3,3)

46.248

Neutral

ATR(14)

0.087

High Vlolatility

CCI(14)

-21.344

Neutral

Williams %R

50.000

Neutral

TRIX(12,20)

0.132

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.194

Sell

MA10

1.204

Sell

MA20

1.181

Sell

MA50

1.179

Sell

MA100

1.231

Sell

MA200

1.574

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer’s disease (AD), and others. The Company is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF) cells. NurOwn leverages cell culture methods to induce autologous bone marrow derived MSCs to secrete high levels of NTFs, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. Autologous MSC-NTF cells is for the treatment of ALS. It has completed a phase III trial in ALS. Its wholly owned subsidiary, BrainStorm Cell Therapeutics Ltd., holds exclusive rights to commercialize NurOwn technology.

Ticker SymbolBCLI

CompanyBrainstorm Cell Therapeutics Inc

CEOMr. Chaim Lebovits

Websitehttps://brainstorm-cell.com/